Effects of general anesthetic agents in adults receiving electroconvulsive therapy: A systematic review

Journal of ECT

Volumn 24, Issue 3, 2008, Pages 208-223

  Hooten, W Michael ^a   Rasmussen, Keith G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Electroconvulsive therapy; General anesthesia; Systematic review

Indexed keywords

ALFADOLONE; ALFAXALONE; ALFENTANIL; ETOMIDATE; METHOHEXITAL; MIDAZOLAM; PROPANIDID; PROPOFOL; REMIFENTANIL; SEVOFLURANE; SUXAMETHONIUM; THIAMYLAL; THIOPENTAL; ANESTHETIC AGENT;

ANESTHESIA INDUCTION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONVALESCENCE; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; EEG ABNORMALITY; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; GENERAL ANESTHESIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; NAUSEA; PARALLEL DESIGN; RISK ASSESSMENT; SEIZURE; SEIZURE THRESHOLD; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STROKE; SUPRAVENTRICULAR PREMATURE BEAT; SYSTEMATIC REVIEW; T WAVE INVERSION; VOMITING; CROSSOVER PROCEDURE; ELECTROENCEPHALOGRAPHY; HEART; METHODOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TIME; TREATMENT OUTCOME;

ANESTHETICS, COMBINED; ANESTHETICS, GENERAL; CROSS-OVER STUDIES; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; HEART; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEIZURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 58749093751     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e31815bfe2a     Document Type: Article

References (76)

1. Weiner R. American Psychiatric Association Committee on Electroconvulsive Therapy. Practice of Electroconvulsive Therapy Recommendations for Treatment, Training and Privileging: A Task Force Report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001.
2. Villalonga A, Bernardo M, Gomar C, et al. Cardiovascular response and anesthetic recovery in electroconvulsive therapy with propofol or thiopental. Convuls Ther. 1993;9:108-111.
3. Rasmussen KG, Jarvis MR, Zorumski CF. Ketamine anesthesia in electroconvulsive therapy. Convuls Ther. 1996;12:217-223.
4. Kovac AL, Pardo M. A comparison between etomidate and methohexital for anesthesia in ECT. Convuls Ther. 1992;8:118-125.
5. Tanaka N, Saito Y, Hikawa Y, et al. Effects of thiopental and sevoflurane on hemodynamics during anesthetic management of electroconvulsive therapy. Masui. 1997;46:1575-1579.
6. Swartz CM. Propofol anesthesia in ECT. Convuls Ther. 1992;8:262-266.
7. Nguyen TT, Chhibber AK, Lustik SJ, et al. Effect of methohexitone and propofol with or without alfentanil on seizure duration and recovery in electroconvulsive therapy. Br J Anaesth. 1997;79:801-803.
8. Fear CF, Littlejohns CS, Rouse E, et al. Propofol anaesthesia in electroconvulsive therapy: reduced seizure duration may not be relevant. Br J Psychiatry. 1994;165:506-509.
9. Martin BA, Cooper RM, Parikh SV. Propofol anesthesia, seizure duration, and ECT: a case report and literature review. J ECT. 1998;14:99-108.
10. Mokriski BK, Nagle SE, Papuchis GC, et al. Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium. J Clin Anesth. 1992;4:208-212.
11. Abrams R. Electroconvulsive Therapy. New York, NY: Oxford University Press; 1997.
12. Review 4.2 [computer program]. Version 4.2 for Windows. Oxford, England: The Cochrane Collaboration; 2004.
13. Elbourne DR, Altman DG, Higgins JP, et al. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002;31:140-149.
14. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
15. Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81:596-602.
16. Recart A, Rawal S, White PF, et al. The effect of remifentanil on seizure duration and acute hemodynamic responses to electroconvulsive therapy. Anesth Analg. 2003;96:1047-1050.
17. Walder B, Seeck M, Tramer MR. Propofol versus methohexital for electroconvulsive therapy: a meta-analysis. J Neurosurg Anesthesiol. 2001;13:93-98.
18. Andersen FA, Arsland D, Holst-Larsen H. Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand. 2001;45:830-833.
19. Bone ME, Wilkins CJ, Lew JK. A comparison of propofol and methohexitone as anaesthetic agents for electroconvulsive therapy. Eur J Anaesthesiol. 1988;5:279-286.
20. Butterfield NN, Graf P, Macleod BA, et al. Propofol reduces cognitive impairment after electroconvulsive therapy. J ECT. 2004;20:3-9.
21. Calarge CA, Crowe RR, Gergis SD, et al. The comparative effects of sevoflurane and methohexital for electroconvulsive therapy. J ECT. 2003;19:221-225.
22. Dwyer R, McCaughey W, Lavery J, et al. Comparison of propofol and methohexitone as anaesthetic agents for electroconvulsive therapy. Anaesthesia. 1988;43:459-462.
23. Fredman B, d'Etienne J, Smith I, et al. Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesth Analg. 1994;79:75-79.
24. Gazdag G, Kocsis N, Tolna J, et al. Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. J ECT. 2004;20:225-229.
25. Geretsegger C, Rochowanski E, Kartnig C, et al. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs. J ECT. 1998;14:28-35.
26. Gurkan Y, Yildiz T, Tural U, et al. Effects of remifentanil on thiopental dose, duration of convulsion and hemodynamic response during electroconvulsive therapy. Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi. 2004;32:269-273.
27. Katre AM, Pandya SH. Comparative evaluation of propanidid with thiopentone as an anaesthetic agent for electro-convulsive therapy. J Postgrad Med. 1980;26:171-177.
28. Koffel Bl, Nagle SE, Papuchis G, et al. Methohexital versus propofol anesthesia for electroconvulsive therapy: cardiac arrhythmias, seizure duration, and recovery times. Anesthesiol Rev. 1994;21:101-107.
29. Lim SK, Lim WL, Elegbe EO. Comparison of propofol and methohexitone as an induction agent in anaesthesia for electroconvulsive therapy. West Afr J Med. 1996;15:186-189.
30. Loughnan T, McKenzie G, Leong S. Sevoflurane versus propofol for induction of anaesthesia for electroconvulsive therapy: a randomized crossover trial. Anaesth Intensive Care. 2004;32:236-240.
31. O'Carroll TM, Blogg CE, Hoinville EA, et al. Etomidate in electroconvulsive therapy. Awithin-patient comparison with alphaxalone/ alphadalone. Anaesthesia. 1977;32:868-872.
32. Rampton AJ, Griffin RM, Stuart CS, et al. Comparison of methohexital and propofol for electroconvulsive therapy: effects on hemodynamic responses and seizure duration. Anesthesiology. 1989;70:412-417.
33. Rasmussen KG, Laurila DR, Brady BM, et al. Seizure length with sevoflurane and thiopental for induction of general anesthesia in electroconvulsive therapy: a randomized double-blind trial. J ECT. 2006;22:240-242.
34. Rouse EC. Propofol for electroconvulsive therapy. A comparison with methohexitone. Preliminary report. Anaesthesia. 1988;43(suppl):61-64.
35. Simpson KH, Halsall PJ, Carr CM, et al. Propofol reduces seizure duration in patients having anaesthesia for electroconvulsive therapy. Br J Anaesth. 1988;61:343-344.
36. Smith DL, Angst MS, Brock-Utne JG, et al. Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy. Acta Anaesthesiol Scand. 2003;47:1064-1066.
37. Stromgren LS, Dahl J, Fjeldborg N, et al. Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines. Acta Psychiatr Scand. 1980;62:158-165.
38. Toprak HI, Gedik E, Begec Z, et al. Sevoflurane as an alternative anaesthetic for electroconvulsive therapy. J ECT. 2005;21:108-110.
39. van den Broek WW, Groenland TH, Kusuma A, et al. Double-blind placebo controlled study of the effects of etomidate-alfentanil anesthesia in electroconvulsive therapy. J ECT. 2004;20:107-111.
40. Vishne T, Aronov S, Amiaz R, et al. Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability. J ECT. 2005;21:235-238.
41. Wajima Z, Shiga T, Yoshikawa T, et al. Propofol alone, sevoflurane alone, and combined propofol-sevoflurane anaesthesia in electroconvulsive therapy. Anaesth Intensive Care. 2003;31:396-400.
42. Zaidi NA, Khan FA. Comparison of thiopentone sodium and propofol for electro convulsive therapy (ECT). J Pak Med Assoc. 2000;50:60-63.
43. Akcaboy ZN, Akcaboy EY, Yigitbasl B, et al. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT. Acta Anaesthesiol Scand. 2005;49:1068-1071.
44. Auriacombe M, Grabot D, Lincheneau P, et al. Use of midazolam for ECT anesthesia: effects on antidepressive efficacy and seizure duration: preliminary findings. Eur Psychiatry. 1995;10:312-316.
45. Christensen P, Kragh-Sorensen P, Sorensen C, et al. EEG-monitored ECT: a comparison of seizure duration under anesthesia with etomidate and thiopentone. Convuls Ther. 1986;2:145-150.
46. Demirel CB, Kati I, Kocoglu H, et al. The effects of propofol and propofol-alfentanil used in electroconvulsive therapy on duration of convulsion, hemodynamic responses and recovery characteristics. Anestezi Dergisi. 2002;10:203-206.
47. Grati L, Louzi M, Nasr K, et al. Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy. Presse Med. 2005;34:282-284.
48. Kirkby KC, Beckett WG, Matters RM, et al. Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Aust N Z J Psychiatry. 1995;29:299-303.
49. Malsch E, Gratz I, Mani S, et al. Efficacy of electroconvulsive therapy after propofol and methohexital anesthesia. Convuls Ther. 1994;10:212-219.
50. Martensson B, Bartfai A, Hallen B, et al. A comparison of propofol and methohexital as anesthetic agents for ECT: effects on seizure duration, therapeutic outcome, and memory. Biol Psychiatry. 1994;35:179-189.
51. Matters RM, Beckett WG, Kirkby KC, et al. Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. Br J Anaesth. 1995;75:297-300.
52. Barron DW, Dundee JW, Gilmore WR, et al. Clinical studies of induction agents. XVI: a comparison of thiopentone, buthalitone, hexobarbitone and thiamylal as induction agents. Br J Anaesth. 1966;38:802-811.
53. Conca A, Germann R, Konig P. Etomidate vs. thiopentone in electroconvulsive therapy. An interdisciplinary challenge for anesthesiology and psychiatry. Pharmacopsychiatry. 2003;36:94-97.
54. Dew RE, Kimball JN, Rosenquist PB, et al. Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental. J ECT. 2005;21:16-18.
55. Dinwiddie SH, Isenberg KE. Combined alfentanil-methohexital anesthesia in electroconvulsive therapy. Convuls Ther. 1995;11:170-176.
56. Foley EI, Walton B, Savege TM, et al. A comparison of recovery times between Althesin and methohexitone following anaesthesia for electro-convulsive therapy. Postgrad Med J. 1972;48(suppl 2):112-115.
57. Gran L, Bergsholm P, Bleie H. Seizure duration in unilateral electroconvulsive therapy. A comparison of the anaesthetic agents etomidate and Althesin with methohexitone. Acta Psychiatr Scand. 1984;69:472-483.
58. Greenan J, Prasad J. Comparison of the ocular effects of atropine or glycopyrrolate with two I.V. induction agents. Br J Anaesth. 1985;57:180-183.
59. Harti A, Hmamouchi B, Idali H, et al. Anesthesia for electroconvulsive therapy: propofol versus thiopental. Encephale. 2001;27:217-221.
60. Hodgson RE, Dawson P, Hold AR, et al. Anaesthesia for electroconvulsive therapy: a comparison of sevoflurane with propofol. Anaesth Intensive Care. 2004;32:241-245.
61. McInnes EJ, James NM. A comparison of ketamine and methohexital in electroconvulsive therapy. Med J Aust. 1972;1:1031-1032.
62. Naftalin AL, Haw ME, Bevans HG. A comparison of propaniid and thiopentone as induction agents for electro-convulsive therapy. Br J Anaesth. 1969;41:506-515.
63. Rudolph P, Weis KH. Short-term anesthesia in shock therapy using methohexital, thiopental and propanidid. Fortschritte der Neurologie, Psychiatrie und Ihrer Grenzgebiete. 1972;40:387-395.
64. Scott A, Boddy H. Induction agents in electroconvulsive therapy: a comparison of methohexitone and propofol. Psychiatr Bull. 2002;26:455-457.
65. Woodruff RA Jr, Pitts FN Jr, McClure JN Jr. The drug modification of ECT. I. Methohexital, thiopental, and preoxygenation. Arch Gen Psychiatry. 1968;18:605-611.
66. Kadoi Y, Saito S, Ide M, et al. The comparative effects of propofol versus thiopentone on left ventricular function during electroconvulsive therapy. Anaesth Intensive Care. 2003;31:172-175.
67. Lemmens HJ, Levi DC, Debattista C, et al. The timing of electroconvulsive therapy and bispectral index after anesthesia induction using different drugs does not affect seizure duration. J Clin Anesth. 2003;15:29-32.
68. Locala JA, Irefin SA, Malone D, et al. The comparative hemodynamic effects of methohexital and remifentanil in electroconvulsive therapy. J ECT. 2005;21:12-15.
69. Boey WK, Lai FO. Comparison of propofol and thiopentone as anaesthetic agents for electroconvulsive therapy. Anaesthesia. 1990;45:623-628.
70. Rampton AJ, Griffin RM, Durcan JJ, et al. Propofol and electroconvulsive therapy. Lancet. 1988;1:296-297.
71. van den Broek WW, Groenland TH, Kusuma A, et al. Alfentanil has no proconvulsive effect during electroconvulsive therapy. Can J Anaesth. 2003;50:198-199.
72. Braasch ER, Demaso DR. Effect of electroconvulsive therapy on serum isoenzymes. Am J Psychiatry. 1980;137:625-626.
73. Sackeim HA, Decina P, Portnoy S, et al. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry. 1987;22:249-268.
74. Swartz CM. Age effect on electroconvulsive therapy seizure resistance. Convuls Ther. 1993;9:181-184.
75. Ottosson JO. Experimental studies of the mode of action of electroconvulsive therapy: introduction. Acta Psychiatr Scand Suppl. 1960;35:5-6.
76. Mitchell P, Torda T, Hickie I, et al. Propofol as an anaesthetic agent for ECT: effect on outcome and length of course. Aust N Z J Psychiatry. 1991;25:255-261.